| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 178 |
| 1 | ADALIMUMAB | 159 |
| 2 | TACROLIMUS | 131 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 118 |
| 4 | TACROLIMUS OINTMENT 0.1% | 118 |
| 5 | MYCOPHENOLATE MOFETIL | 111 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 111 |
| 7 | METHYLPREDNISOLONE | 100 |
| 8 | ACETAMINOPHEN | 96 |
| 9 | OMEPRAZOLE MAGNESIUM | 92 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONTRUZANT | 5 | 0.0096 |
| 1 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 2 | CEFOTETAN | 1 | 0.0075 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 40 | 0.0048 |
| 4 | CHLOROTHIAZIDE | 6 | 0.0048 |
| 5 | CASPOFUNGIN ACETATE | 7 | 0.0044 |
| 6 | CHLOROTHIAZIDE SODIUM | 4 | 0.0043 |
| 7 | DEXRAZOXANE FOR INJECTION | 4 | 0.0042 |
| 8 | INFLIXIMAB-DYYB | 14 | 0.0041 |
| 9 | TIGECYCLINE | 20 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 382 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 183 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 175 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 139 |
| 4 | Platinum-based Drug [EPC] | 121 |
| 5 | Proton Pump Inhibitor [EPC] | 113 |
| 6 | Kinase Inhibitor [EPC] | 105 |
| 7 | Benzodiazepine [EPC] | 92 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 91 |
| 9 | Microtubule Inhibitor [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 2 | Tetracycline-class Antibacterial [EPC] | 20 | 0.0025 |
| 3 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 4 | Provitamin D2 Compound [EPC] | 70 | 0.0024 |
| 5 | Human Immunoglobulin G [EPC] | 30 | 0.0014 |
| 6 | Actinomycin [EPC] | 3 | 0.0014 |
| 7 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 8 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |